AIkido Pharma Inc. is a biotechnology company that specializes in developing anti-cancer therapeutics and antiviral platforms. The company's pipeline of therapies includes treatment options for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia. AIkido Pharma also has license agreements with several universities and is based in New York City.